Crawford Ed

412 total citations
27 papers, 334 citations indexed

About

Crawford Ed is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Crawford Ed has authored 27 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 5 papers in Oncology. Recurrent topics in Crawford Ed's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Crawford Ed is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Crawford Ed collaborates with scholars based in United States, Netherlands and Canada. Crawford Ed's co-authors include Serdar Göktaş, Ali Ziada, Von Hoff, Anibal Drelichman, Kelloff Gj, Ronald Lieberman, Fernand Labrie, P.T. Scardino, John A. Sullivan and J. Montie and has published in prestigious journals such as Urologic Oncology Seminars and Original Investigations, Prostate Cancer and Prostatic Diseases and Europe PMC (PubMed Central).

In The Last Decade

Crawford Ed

27 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Crawford Ed United States 11 200 74 72 54 45 27 334
Thomas H. Douglas United States 10 411 2.1× 129 1.7× 63 0.9× 81 1.5× 69 1.5× 12 503
T Billebaud France 8 409 2.0× 47 0.6× 101 1.4× 50 0.9× 24 0.5× 29 490
B Otnes Norway 12 276 1.4× 93 1.3× 72 1.0× 82 1.5× 31 0.7× 29 421
Franklin Gaylis United States 12 281 1.4× 102 1.4× 116 1.6× 96 1.8× 96 2.1× 38 506
W A Sakr United States 7 605 3.0× 102 1.4× 136 1.9× 144 2.7× 112 2.5× 10 738
Jean-François Caubet United States 6 255 1.3× 200 2.7× 51 0.7× 114 2.1× 44 1.0× 8 473
Raghu Rajan Canada 10 104 0.5× 94 1.3× 101 1.4× 24 0.4× 42 0.9× 21 375
Eric A. Klein United States 8 374 1.9× 34 0.5× 109 1.5× 44 0.8× 34 0.8× 14 477
Oskar Bergengren Sweden 7 268 1.3× 151 2.0× 56 0.8× 109 2.0× 87 1.9× 13 475
Raphael Pfeffer Israel 4 622 3.1× 71 1.0× 86 1.2× 30 0.6× 74 1.6× 5 660

Countries citing papers authored by Crawford Ed

Since Specialization
Citations

This map shows the geographic impact of Crawford Ed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crawford Ed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crawford Ed more than expected).

Fields of papers citing papers by Crawford Ed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crawford Ed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crawford Ed. The network helps show where Crawford Ed may publish in the future.

Co-authorship network of co-authors of Crawford Ed

This figure shows the co-authorship network connecting the top 25 collaborators of Crawford Ed. A scholar is included among the top collaborators of Crawford Ed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crawford Ed. Crawford Ed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ed, Crawford, et al.. (2015). Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.. PubMed. 22(6). 8048–55. 10 indexed citations
2.
Ed, Crawford, et al.. (2012). Advanced prostate cancer: therapeutic sequencing, outcomes, and cost implications.. PubMed. 18(5 Spec No.). SP250–3. 2 indexed citations
3.
Ed, Crawford. (2003). The role of the urologist in treating patients with hormone-refractory prostate cancer.. Europe PMC (PubMed Central). 5 Suppl 2. S48–52. 15 indexed citations
4.
Ed, Crawford, et al.. (2003). Prostate cancer update.. PubMed. 55(4). 199–204. 1 indexed citations
5.
Elias, Laurence, et al.. (2002). Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-α for the treatment of patients with advanced renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 7(2). 83–83. 1 indexed citations
6.
Ziada, Ali, et al.. (2000). Advanced prostate cancer: an update.. PubMed. 2 Suppl 4. S35–9. 1 indexed citations
7.
Ed, Crawford, et al.. (2000). Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy.. PubMed. 6(2). 60–3. 22 indexed citations
8.
Gj, Kelloff, et al.. (1999). Strategies for chemoprevention of prostate cancer. Prostate Cancer and Prostatic Diseases. 2(S1). 27–33. 21 indexed citations
9.
Ziada, Ali & Crawford Ed. (1999). Advanced prostate cancer. Prostate Cancer and Prostatic Diseases. 2(S1). 21–26. 53 indexed citations
10.
Ed, Crawford, et al.. (1998). Prevalence and natural history of urinary symptoms in a longitudinal national prostate cancer screening (community-based) study. Prostate Cancer and Prostatic Diseases. 1(5). 256–261. 4 indexed citations
11.
Göktaş, Serdar, et al.. (1997). A cross-sectional study of vasectomy, time since vasectomy and prostate cancer. Prostate Cancer and Prostatic Diseases. 1(2). 73–78. 8 indexed citations
12.
Ed, Crawford, et al.. (1994). Intravesical RTNF therapy of superficial bladder cancer. A phase I study of recombinant tumor necrosis factor administered intravesically to patients with superficial bladder cancer.. PubMed. Doc No 117. [4845 words; 36 paragraphs]–[4845 words; 36 paragraphs]. 1 indexed citations
13.
Ed, Crawford, et al.. (1990). Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080).. PubMed. 353. 111–3. 15 indexed citations
14.
Blumenstein, Brent A., Crawford Ed, J. Montie, et al.. (1989). Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.. PubMed. 310. 263–70. 31 indexed citations
15.
Slavík, M, et al.. (1987). Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.. PubMed. 71(2). 207–8. 6 indexed citations
16.
Blumenstein, Brent A., et al.. (1987). Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group Study.. PubMed. 71(12). 1305–6. 1 indexed citations
17.
Ed, Crawford, et al.. (1987). Aminoglutethimide in metastatic adenocarcinoma of the prostate.. PubMed. 243A. 283–9. 8 indexed citations
18.
Ed, Crawford, et al.. (1987). Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.. PubMed. 47(17). 4736–9. 13 indexed citations
19.
Ed, Crawford. (1984). The Southwest Oncology Group Study for advanced testicular cancer.. PubMed. 2(4). 244–53. 2 indexed citations
20.
Drelichman, Anibal, et al.. (1983). Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.. PubMed. 67(12). 1133–5. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026